Dipharma Francis is proud to announce that Anna Simonetto, R&D Researcher, has been selected as a speaker at the 4th Empowering Women in Organic Chemistry (EWOC) Europe Conference, taking place on 29–30 June 2026 at the Institut Català d’Investigació Química (ICIQ) in Tarragona, Spain.
Under the theme “Organic Chemistry for All: Empowering Women and Engaging Allies,” EWOC brings together scientists from academia and industry to foster networking, scientific exchange, and career development opportunities for women in Organic Chemistry.
As recent studies continue to highlight the underrepresentation of women in the field, initiatives like EWOC play a crucial role in promoting a more inclusive and diverse scientific community.
At Dipharma Francis, we strongly support these values through our sponsorship of the event, and are committed to creating opportunities for talented scientists to grow, contribute, and lead innovation.
Anna Simonetto is among the four early-career scientists invited to speak during Early Career Session 1, a dedicated platform showcasing outstanding women chemists at the early stages of their careers.
In her presentation, “Hunt for NDSRIs: Unveiling Hidden Threats with the Novel ¹⁵N-Enriched NAP Test,” Anna will explore the complexity of nitrosamine impurities, presenting Dipharma’s risk assessment protocol and several innovative investigative approaches developed by our team. Among these, she will highlight the groundbreaking application of ¹⁵N-NMR methodology, providing practical insights into how advanced science and technology can help address one of the most critical challenges facing pharmaceutical development and manufacturing today.
This recognition reflects both Anna’s scientific expertise and Dipharma’s ongoing commitment to advancing innovative solutions that safeguard product quality, patient safety, and regulatory compliance.
Congratulations, Anna, on this well-deserved achievement. We are proud to see you represent Dipharma Francis on the international stage.
This established approach has been published in a peer-reviewed article in Organic Process Research & Development (OPR&D), (https://pubs.acs.org/doi/10.1021/acs.oprd.5c00223),
To learn more about Dipharma’s approach to nitrosamine risk assessment and mitigation, explore the white paper: “Extinguishing Nitrosamine Risk: How Dipharma Safeguards Your Product Quality”, available here: https://www.dipharma.com/download-area/
To explore our innovative solutions, expertise, and capabilities, please contact us.
Experience you can trust
For more information:
Paola Clerici
Communication Manager
Dipharma Francis S.r.l.
paola.clerici@dipharma.com
